EMD-49235

Single-particle
3.23 Å
EMD-49235
3D View Gallery
Deposition: 14/02/2025
Map released: 06/08/2025
Last modified: 06/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-49235

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map)

Recombinant A(H5N1) A/American Wigeon/South Carolina/22/000345-001/2021 (A/AW/SC/2021) clade 2.3.4.4b nanoparticle in complex with mouse monoclonal antibody NVX.73.2

EMD-49235

Single-particle
3.23 Å
EMD-49235
3D View Gallery
Deposition: 14/02/2025
Map released: 06/08/2025
Last modified: 06/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: H5N1 subtype
Sample: Recombinant A(H5N1) A/American Wigeon/South Carolina/22/000345-001/2021 (A/AW/SC/2021) clade 2.3.4.4b nanoparticle in complex with mouse monoclonal antibody NVX.73.2

Deposition Authors: Smith G , Patel A, Rehman A
Single-dose avian influenza A(H5N1) Clade 2.3.4.4b hemagglutinin-Matrix-M ® nanoparticle vaccine induces neutralizing responses in nonhuman primates.
Patel N, Rehman A , Trost JF , Flores R, Longacre Z, Guebre-Xabier M, Zhou H, Zhou B, Jacobson K, Jiang D, Bai X, Khatoon R, Kort T, Norton J, Madhangi M, Hersey M, Greene AM , Dubovsky F, Smith G
(2025) Nat Commun , 16 , 6625 - 6625
PUBMED: 40681543
DOI: doi:10.1038/s41467-025-61964-y
ISSN: 2041-1723
Grant Support: